We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

461 hedge funds and large institutions have $9.45B invested in United Therapeutics in 2022 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 170 increasing their positions, 160 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

104% more call options, than puts

Call options by funds: $104M | Put options by funds: $51M

2.74% more ownership

Funds ownership: 97.2% → 99.94% (+2.7%)

6% more repeat investments, than reductions

Existing positions increased: 170 | Existing positions reduced: 160

2% less funds holding

Funds holding: 472 → 461 (-11)

9% less capital invested

Capital invested by funds: $10.3B → $9.45B (-$878M)

11% less first-time investments, than exits

New positions opened: 54 | Existing positions closed: 61

25% less funds holding in top 10

Funds holding in top 10: 24 → 18 (-6)

Holders
461
Holders Change
-11
Holders Change %
-2.33%
% of All Funds
7.94%
Holding in Top 10
18
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-25%
% of All Funds
0.31%
New
54
Increased
170
Reduced
160
Closed
61
Calls
$104M
Puts
$51M
Net Calls
+$53.1M
Net Calls Change
+$3.64M

Top Buyers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$211M
2
Citadel Advisors
Citadel Advisors
Florida
+$124M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$63.7M
4
APM
Avidity Partners Management
Texas
+$54.7M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$36.6M

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
-$54.4M
2
PAMS
Pictet Asset Management (Switzerland)
Switzerland
-$41.7M
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$39M
4
American Century Companies
American Century Companies
Missouri
-$36.1M
5
First Trust Advisors
First Trust Advisors
Illinois
-$35.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Adage Capital Partners
26
Adage Capital Partners
Massachusetts
$74.3M +$31.3M +140,000 +65%
PCM
27
Polaris Capital Management
Massachusetts
$71.6M -$2.08M -9,300 -3%
Northern Trust
28
Northern Trust
Illinois
$70.3M -$212K -947 -0.3%
Charles Schwab
29
Charles Schwab
California
$62.7M -$22.2M -99,104 -25%
AQR Capital Management
30
AQR Capital Management
Connecticut
$61.3M -$13.2M -58,990 -17%
Invesco
31
Invesco
Georgia
$59.6M +$2.9M +12,971 +5%
EIP
32
Epoch Investment Partners
New York
$56.6M -$5.87M -26,243 -9%
AssetMark Inc
33
AssetMark Inc
California
$55.8M +$12M +53,855 +25%
Morgan Stanley
34
Morgan Stanley
New York
$53.6M -$20M -89,313 -26%
EP
35
Eversept Partners
New York
$53.4M -$12.4M -55,608 -18%
SCM
36
Soleus Capital Management
Connecticut
$49.2M -$13.6M -60,682 -21%
Allspring Global Investments
37
Allspring Global Investments
North Carolina
$47.3M -$3.03M -13,541 -6%
VOYA Investment Management
38
VOYA Investment Management
Georgia
$45.5M +$3.31M +14,795 +7%
Allianz Asset Management
39
Allianz Asset Management
Germany
$45.1M +$2.78M +12,425 +6%
Loomis, Sayles & Company
40
Loomis, Sayles & Company
Massachusetts
$42.6M +$8.42M +37,643 +23%
KAM
41
Krensavage Asset Management
New York
$42M -$184K -821 -0.4%
Deutsche Bank
42
Deutsche Bank
Germany
$41M -$236K -1,055 -0.5%
Goldman Sachs
43
Goldman Sachs
New York
$40.7M -$2.97M -13,265 -6%
FCM
44
Frontier Capital Management
Massachusetts
$39.2M -$5.71M -25,551 -12%
First Manhattan
45
First Manhattan
New York
$38.4M +$12.8M +57,200 +45%
JP Morgan Chase
46
JP Morgan Chase
New York
$37.7M -$891K -3,984 -2%
Principal Financial Group
47
Principal Financial Group
Iowa
$37.5M -$25.1M -112,086 -38%
Prudential Financial
48
Prudential Financial
New Jersey
$37M +$17.6M +78,671 +80%
PFC
49
Poplar Forest Capital
California
$35.2M +$32.4K +145 +0.1%
CAPTRUST Financial Advisors
50
CAPTRUST Financial Advisors
North Carolina
$35M +$6.14M +27,467 +20%
1
2
3 4 5

UTHR Hedge Fund Activity: Q3 2022 in Review

461 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q3 2022, worth a combined $9.45B — down 8.5% from $10.3B a quarter earlier.

Sellers outnumbered buyers: 61 funds closed out of UTHR and 54 opened new positions — a net loss of 7 holders — while 160 trimmed existing stakes and 170 added.

The largest buyer was Janus Henderson Group, adding an estimated $211M. The largest seller was Renaissance Technologies, cutting an estimated $54.4M.

  • 461 institutional investors held United Therapeutics (UTHR) as of Q3 2022, down from 472 in Q2 2022.
  • Funds reported $9.45B of United Therapeutics stock for Q3 2022, down 8.5% quarter-over-quarter.
  • 54 funds opened new United Therapeutics positions in Q3 2022 and 61 closed out, a net change of -7 holders.
  • The largest United Therapeutics buyer in Q3 2022 was Janus Henderson Group, an estimated $211M added.
  • The largest United Therapeutics seller in Q3 2022 was Renaissance Technologies, an estimated $54.4M sold.

Based on aggregated 13F filings for Q3 2022.